Best Alternatives to Botox for Chronic Migraine in 2026

Botox (onabotulinumtoxinA) is one of the most established preventive options for chronic migraine, but it is not the only one, and it is not the right fit for everyone. Some people want to avoid repeat injections every 12 weeks. Others see only a partial response, face cost or access barriers, or simply prefer a non-drug starting point.

The good news in 2026: the list of evidence-based alternatives is longer than it has ever been. It now spans behavioral programs, newer migraine-specific medications, wearable devices, and lifestyle approaches. This guide walks through the strongest options, what the research actually shows for each, and who each one tends to suit.

Key Takeaways

• Chronic migraine is defined as headache on 15 or more days per month for more than 3 months, with migraine features on at least 8 of those days.
• Botox is FDA-approved for chronic migraine prevention, but it requires injections every 12 weeks and is not approved for episodic migraine.
• Behavioral, brain-first programs like Lin Health offer a non-injection, non-drug path that may reduce migraine frequency for some adults and works alongside medical care.
• The American Headache Society now considers CGRP-targeting therapies (monoclonal antibodies and gepants) a first-line option for prevention.
• The right alternative depends on your migraine pattern, treatment history, and preferences, so any change is best made with a clinician.

How We Chose These Alternatives

Every option below is either FDA-approved, FDA-cleared, or supported by recent peer-reviewed evidence for migraine specifically. Where the evidence is strong, we say so. Where it is limited or uncertain, we say that too. Chronic migraine is an active research area, so this guide prioritizes findings from the last few years and current society guidance over older sources.

1. Lin Health: A Brain-First Behavioral Program

For people who want an alternative to repeat injections, a behavioral, brain-first program is one of the most compelling non-drug options available in 2026. Lin Health is built around this approach, and it is the option we cover first.

Lin Health is not physical therapy, medication, or injections. It is a structured program delivered by trained recovery coaches, supported by an app with guided lessons and practices. Care is covered by insurance in high-coverage states and starts with a same-day callback, so people often begin within days rather than months.

How it works

The approach is based on the science of how chronic pain and persistent symptoms can become "stuck." After an initial trigger, the brain's alarm system can keep firing even when there is no ongoing danger, reinforcing a learned pattern over time. Lin Health's program works to retrain that response by addressing the fear, emotions, and thought loops that keep the alarm active, an approach rooted in brain-based pain science.

What the evidence shows

Behavioral approaches have migraine-specific research behind them. A 2025 systematic review found that cognitive behavioral therapy, relaxation training, and mindfulness-based therapies may reduce migraine frequency in adults, though the strength of evidence is rated low and results vary between people. Lin Health's program is based on this behavioral evidence base, applied alongside (not instead of) medical migraine care.

Who it tends to suit

People who want to avoid more injections or medication, who have not gotten full relief from drugs alone, or who want to address the nervous-system side of chronic migraine. It pairs well with medical prevention rather than replacing a clinician's plan. You can read more in Lin Health's chronic migraine condition guide.

2. CGRP Monoclonal Antibodies

CGRP monoclonal antibodies are injectable or infused medications designed specifically for migraine prevention. The four available agents are erenumab, fremanezumab, galcanezumab, and eptinezumab.

In 2024, the American Headache Society stated that CGRP-targeting therapies should be considered a first-line option for prevention, without requiring a person to fail older medications first. In chronic migraine, these antibodies reduce monthly migraine days compared with placebo and increase the share of people who achieve at least a 50 percent reduction in migraine days, though response rates vary by agent.

Who it tends to suit: People who want a migraine-specific medication, are comfortable with a monthly self-injection (or quarterly infusion for eptinezumab), and want a first-line preventive backed by strong recent evidence.

3. Gepants for Prevention

Gepants are oral medications that block the CGRP pathway in pill form rather than by injection. Atogepant is the one most relevant here. In April 2023, the FDA approved atogepant for chronic migraine, making it the first oral CGRP receptor antagonist approved for both episodic and chronic migraine.

The decision was based on the phase 3 PROGRESS trial, which met its primary endpoint of reducing monthly migraine days in adults with chronic migraine. Rimegepant is another gepant approved for migraine prevention.

Who it tends to suit: People who prefer a daily pill over injections and want a newer migraine-specific preventive.

4. Neuromodulation Devices

Neuromodulation devices use mild electrical or magnetic stimulation to influence the nerves involved in migraine. Several are FDA-cleared for migraine, including Cefaly (external trigeminal stimulation), Nerivio (remote electrical neuromodulation), gammaCore (vagus nerve stimulation), SAVI Dual, and Relivion.

The honest picture on evidence is mixed. International Headache Society guidelines issue only weak recommendations for devices in prevention, and the quality of evidence ranges from very low to moderate. Notably, trials of vagus nerve stimulation (gammaCore) did not meet their primary endpoints, even though some other measures were positive. Devices appeal to people who want a drug-free option with a favorable safety profile, but expectations should be realistic.

Who it tends to suit: People who want a non-drug device, often as an add-on to other prevention, and who can accept that the evidence is still developing.

5. Oral Preventive Medications

Before CGRP drugs arrived, oral preventives were the mainstay, and they remain widely used and inexpensive. The classes with the most support include topiramate, beta-blockers, and valproate, which are established as effective and recommended for prevention. Amitriptyline is probably effective, and candesartan is possibly effective.

Taken regularly, topiramate and valproate roughly double the likelihood of a 50 percent or greater reduction in migraine frequency compared with placebo. Much of the formal guideline evidence, including the American College of Physicians' 2024 prevention guideline, focuses on episodic migraine, so a clinician's judgment matters when applying these to chronic migraine.

Who it tends to suit: People who want a low-cost option, or who have another condition (such as high blood pressure) that an oral preventive can address at the same time.

6. Behavioral Therapies

Beyond a structured program like Lin Health, individual behavioral therapies are worth understanding on their own. The 2025 evidence review found that cognitive behavioral therapy, relaxation training, and mindfulness-based therapies may reduce migraine frequency in adults, at a low strength of evidence.

It is worth being precise about the limits: in that same review, the evidence for biofeedback, acceptance and commitment therapy, and hypnotherapy was insufficient to draw firm conclusions in adults. These approaches are low-risk and pair naturally with medical prevention, which is part of why they are increasingly offered alongside it. Lin Health's program draws on evidence-based CBT approaches and migraine-specific practices such as imaginal exposure for triggers.

Who it tends to suit: People who want to address stress, fear of attacks, and the emotional side of chronic migraine, usually in combination with other prevention.

7. Lifestyle and Nutraceutical Approaches

Day-to-day habits and a few supplements round out the toolkit. They rarely replace medical prevention, but they can support it.

• Aerobic exercise. Recent meta-analyses show aerobic exercise reduces migraine frequency and pain intensity, with benefits growing as total exercise volume increases. A commonly studied routine is about three 30-minute sessions per week.
• Magnesium. Rated Level B ("probably effective") by neurology and headache societies for migraine prevention.
• Riboflavin (vitamin B2) and CoQ10. Riboflavin has supportive evidence, and CoQ10 is rated possibly effective.
• Consistent sleep and routine. Regular sleep and meal timing are commonly recommended as part of a prevention plan.

Supplements can interact with other treatments and are not risk-free, so it is worth discussing doses with a clinician before starting.

Who it tends to suit: Nearly everyone as a foundation, layered under whichever primary prevention you choose.

How Lin Health Helps With Chronic Migraine

If you have tried medications or injections and still have frequent migraine days, the nervous-system side of chronic migraine may be an underused lever. This is where Lin Health focuses.

Lin Health's approach is based on the science of central sensitization and neuroplastic pain: the idea that a persistent alarm in the brain and nervous system can be retrained over time. Rather than a book or a self-guided app alone, the program pairs you with a recovery coach for live sessions and between-session support, backed by structured modules drawn from behavioral approaches like CBT and ACT.

What tends to set it apart for people seeking an alternative to repeat injections:

• Non-drug and non-injection. A primary path for people who want to avoid more medication or needles.
• Insurance-covered. Care is covered by most plans in Colorado, Texas, Florida, California, and New York, with some coverage elsewhere. Many patients pay nothing out of pocket.
• Short wait times. A same-day callback checks your eligibility, so you can often start within days.
• Specialized. Coaches focus on chronic pain and persistent symptoms, not general talk therapy.

People have used this kind of approach to regain control over symptoms, and Lin Health partners with headache-focused clinics such as the NY Headache Center.

If injections have not been the right fit, a brain-first behavioral program may be worth exploring alongside your medical care for chronic migraine. Check your eligibility - most patients in covered states pay zero out of pocket, and the first call is usually same-day.

FAQ

What is the most effective alternative to Botox for chronic migraine?

There is no single best option for everyone. CGRP therapies have strong recent evidence and are now considered first-line, while behavioral programs offer a non-drug path. The right choice depends on your migraine pattern, history, and preferences, so decide with a clinician.

Can you prevent chronic migraine without medication or injections? 

For some adults, yes, at least in part. Behavioral therapies, regular aerobic exercise, and a structured brain-first program may reduce migraine frequency. These approaches are usually most effective alongside, rather than instead of, medical care.

Are CGRP medications better than Botox? 

Both reduce migraine days in chronic migraine. CGRP therapies are now a first-line option and include pills and self-injections, while Botox is given as injections every 12 weeks. Neither is universally better, and many people try more than one.

Do migraine devices like Cefaly or Nerivio actually work?

They are FDA-cleared and low-risk, but the evidence is mixed and rated weak in current guidelines. They may help some people, often as an add-on. Trials of vagus nerve stimulation did not meet their primary endpoints.

Is Lin Health covered by insurance?

Lin Health is covered by most insurance plans in Colorado, Texas, Florida, California, and New York, with some coverage in other states. A same-day callback checks your eligibility, and many patients pay nothing out of pocket.

How is chronic migraine different from regular migraine?

Chronic migraine means headache on 15 or more days per month for more than 3 months, with migraine features on at least 8 of those days. Fewer than 15 headache days per month is classified as episodic migraine.

The Bottom Line

In 2026, people with chronic migraine have more alternatives to Botox than ever, from first-line CGRP therapies and oral preventives to devices, lifestyle changes, and brain-first behavioral programs. Behavioral approaches like Lin Health stand out as a non-drug, non-injection path that works alongside medical care and is covered by insurance in several states. Because the right plan depends on your individual pattern, the most reliable next step is a conversation with a clinician about which combination fits you.

This article is for informational purposes and is not medical advice. Treatment names and approvals reflect information available as of 2026. Talk with a qualified healthcare provider before starting, stopping, or changing any migraine treatment.